Eledon Pharmaceuticals (ELDN) Preferred Stock Liabilities (2013 - 2026)
Eledon Pharmaceuticals (ELDN) reported Preferred Stock Liabilities of $39.02 million for Q2 2026, down 29.9% from $55.69 million a year earlier and down 29.9% from the prior quarter.
Powered by 
Analysis
Eledon Pharmaceuticals (ELDN) Preferred Stock Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Eledon Pharmaceuticals posted Preferred Stock Liabilities of $55.69 million, unchanged from FY2024.
- Preferred Stock Liabilities has a three-year compound annual growth rate of -2.7% (FY2022 to FY2025).
- By year, Preferred Stock Liabilities came in at $55.69 million in FY2024 (unchanged), $55.69 million in FY2023 (-7.8%) and $60.4 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Preferred Stock Liabilities in data going back to Q4 2013.
- Over the past five years, the year-over-year decline in Preferred Stock Liabilities ranged from 0.0% (Q1 2026) to 29.9% (Q2 2026).
- Per Business Quant data, the three quarters before Q2 2026 came in at $55.69 million (Q1 2026), $55.69 million (Q4 2025) and $55.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Eledon Pharmaceuticals | 258.51 Mn | 169.71 Mn | - | 39.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.02 Mn |
| Mar 31, 2026 | 55.69 Mn |
| Dec 31, 2025 | 55.69 Mn |
| Sep 30, 2025 | 55.69 Mn |
| Jun 30, 2025 | 55.69 Mn |
| Mar 31, 2025 | 55.69 Mn |
| Dec 31, 2024 | 55.69 Mn |
| Sep 30, 2024 | 55.69 Mn |
| Jun 30, 2024 | 55.69 Mn |
| Mar 31, 2024 | 55.69 Mn |
| Dec 31, 2023 | 55.69 Mn |
| Dec 31, 2022 | 60.40 Mn |
| Sep 30, 2020 | 164.95 Mn |
| Dec 31, 2013 | 85.35 Mn |
API Access
Eledon Pharmaceuticals Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ELDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "ELDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ELDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();